SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-019220
Filing Date
2022-03-16
Accepted
2022-03-16 16:17:01
Documents
1
Period of Report
2022-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3867
  Complete submission text file 0001209191-22-019220.txt   5472
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O SEATTLE GENETICS, INC. 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
HIMES VAUGHN B (Reporting) CIK: 0001361966 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 22745079